EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Diabetic retinopathy: a comprehensive review of pathophysiology and emerging treatments

Mukul Shyam, S Sidharth, Aleen Veronica, Lakshmipriya Jagannathan, Prathap Srirangan, Vidya Radhakrishnan, Evan Prince Sabina

Molecular Biology Reports · 2025-12 · 52 (1)

DOI: 10.1007/s11033-025-10490-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 10.04.2025. Verfasst von Mukul Shyam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, India. Hauptthemen laut MEDLINE: Diabetic Retinopathy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: VIT SEED GRANT(RGEMS), VIT SEED GRAN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy constitutes a major complication associated with diabetes mellitus, resulting in visual impairment and blindness on a global scale. The pathophysiology of DR is characterized by intricate interactions among metabolic, hemodynamic, and inflammatory pathways, which include the activation of the polyol pathway, the accumulation of advanced glycation end products, the overactivation of protein kinase C, dysregulation of the renin-angiotensin-aldosterone system, and retinal neurodegeneration. This review investigates the classification, complex pathophysiology, and therapeutic modalities for DR, encompassing conventional interventions such as anti-VEGF agents, aldose reductase inhibitors, angiotensin receptor blockers, laser photocoagulation, and vitrectomy. Innovative treatments, including advanced anti-VEGF agents, neuroprotective strategies, gene and stem cell therapies, and advancements in drug delivery systems, exhibit considerable transformative potential. Furthermore, integrating artificial intelligence for early detection and modulation of inflammatory pathways signifies cutting-edge progress in the field. By integrating contemporary knowledge and prospective avenues, this review underscores the significance of comprehending the multifaceted nature of DR and the advancements in its therapeutic approaches. The objective is to bridge the gaps between research findings and clinical application, thereby providing a comprehensive resource to enhance outcomes and quality of life for individuals impacted by DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyHumansRenin-Angiotensin SystemAnimalsVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

Anti- VEGF agentsDiabetic retinopathyLaser photocoagulationPolyol pathwayVisual impairment

Substanzen

Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, India.
  • VIT School of Agricultural Innovations and Advanced Learning, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
  • Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, India. epsabina@vit.ac.in.

Förderung

  • VIT SEED GRANT(RGEMS)
  • VIT SEED GRAN

Zitieren

APA

Shyam, M., Sidharth, S., Veronica, A., Jagannathan, L., Srirangan, P., Radhakrishnan, V., & Sabina, E. P. (2025). Diabetic retinopathy: a comprehensive review of pathophysiology and emerging treatments. Molecular Biology Reports, 52(1). https://doi.org/10.1007/s11033-025-10490-7

Vancouver

Shyam M, Sidharth S, Veronica A, Jagannathan L, Srirangan P, Radhakrishnan V, et al. Diabetic retinopathy: a comprehensive review of pathophysiology and emerging treatments. Molecular Biology Reports. 2025;52(1). doi:10.1007/s11033-025-10490-7

BibTeX
@article{Shyam2025,
  author = {Shyam, Mukul and Sidharth, S and Veronica, Aleen and Jagannathan, Lakshmipriya and Srirangan, Prathap and Radhakrishnan, Vidya and Sabina, Evan Prince},
  title = {Diabetic retinopathy: a comprehensive review of pathophysiology and emerging treatments},
  journal = {Molecular Biology Reports},
  year = {2025},
  volume = {52},
  number = {1},
  doi = {10.1007/s11033-025-10490-7}
}
Kostenlos starten →